| QADYNA PFIZER INC.
1721511 30 Mar 2015 | on 22 Aug 2019 | Class 005 Class 005 Pharmaceutical Products Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely amyloidosis. | | | QADYNA FOLDRX PHARMACEUTICALS INC.
A DELAWARE CORPORATION
1501414 27 Oct 2010 | on 20 May 2015 | Class 005 Class 005 Pharmaceutical Products Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely, amyloidosis. | |